share_log

Wedbush Reiterates Neutral on CytomX Therapeutics, Maintains $3 Price Target

Moomoo 24/7 ·  Mar 12 08:24

Wedbush analyst Robert Driscoll reiterates CytomX Therapeutics (NASDAQ:CTMX) with a Neutral and maintains $3 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment